2020
DOI: 10.26434/chemrxiv.12948746.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense Therapy

Abstract: <p></p><p>As of July 25-2020, 643,412 people in more than 215 countries have been victims of the new type of coronavirus, SARS-CoV-2. Thereby, there is a huge effort to develop a strategy to treat, and or prevent people from SARS-CoV-2 infection. Those efforts could be mainly categorized as drug repurposing, anti-SARS-CoV-2 antibodies from people who recovered, and vaccines. However, there is currently no specific treatment available against SARS-CoV-2 infected patients. That`s why many new a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…(13) Secondly, because of the hydrophobicity of nucleobases and the backbone flexibility, mRNA can fold into different 3D motifs which can interfere with the mRNA-ASO hybridization and the selectivity. (12) Thus, one either tries to target more unstructured regions of mRNA (14) or screen large libraries of different ASOs. (2,12) Recent studies have highlighted the importance of taking the 3D structure of RNA targets into account in the design of ASOs.…”
Section: Introductionmentioning
confidence: 99%
“…(13) Secondly, because of the hydrophobicity of nucleobases and the backbone flexibility, mRNA can fold into different 3D motifs which can interfere with the mRNA-ASO hybridization and the selectivity. (12) Thus, one either tries to target more unstructured regions of mRNA (14) or screen large libraries of different ASOs. (2,12) Recent studies have highlighted the importance of taking the 3D structure of RNA targets into account in the design of ASOs.…”
Section: Introductionmentioning
confidence: 99%